Clinical Trial Update: Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals

View source ↗

Summary

This completed clinical trial characterizes the early pathobiology of lung destruction in individuals with alpha-1 antitrypsin deficiency, contributing to under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Emphysema, Lung Diseases, Obstructive | Status: COMPLETED